NASOPHARYNGEAL REFLUX

NASOPHARYNGEAL REFLUX was reported 41 times

NASOPHARYNGEAL REFLUX is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Benzothiazole [EPC] 1 0.0004
1 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1 0.0001
2 Anticholinergic [EPC] 1 0.0001
3 Carbonic Anhydrase Inhibitor [EPC] 1 0.0000
4 Acetylcholine Release Inhibitor [EPC] 4 0.0000
5 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
6 Anti-epileptic Agent [EPC] 5 0.0000
7 Mood Stabilizer [EPC] 4 0.0000
8 Prostacycline Vasodilator [EPC] 2 0.0000
9 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
10 Prostaglandin Analog [EPC] 1 0.0000
11 Partial Opioid Agonist [EPC] 1 0.0000
12 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
13 5-alpha Reductase Inhibitor [EPC] 1 0.0000
14 Expectorant [EPC] 2 0.0000
15 Antirheumatic Agent [EPC] 1 0.0000
16 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
17 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
18 Opioid Agonist [EPC] 2 0.0000
19 Osmotic Laxative [EPC] 2 0.0000
20 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
21 Janus Kinase Inhibitor [EPC] 1 0.0000
22 Proton Pump Inhibitor [EPC] 3 0.0000
23 Endothelin Receptor Antagonist [EPC] 1 0.0000
24 Insulin Analog [EPC] 2 0.0000
25 Corticosteroid [EPC] 5 0.0000
26 Factor Xa Inhibitor [EPC] 1 0.0000
27 Platelet Aggregation Inhibitor [EPC] 2 0.0000
28 beta-Adrenergic Blocker [EPC] 1 0.0000
29 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
30 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
31 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
32 Vitamin C [EPC] 1 0.0000
33 Loop Diuretic [EPC] 1 0.0000
34 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
35 Thalidomide Analog [EPC] 1 0.0000
36 Tumor Necrosis Factor Blocker [EPC] 1 0.0000